IMR Press / CEOG / Volume 36 / Issue 3 / pii/1630635721160-1160491509

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
Mid-trimester maternal serum hCG levels in predicting adverse pregnancy outcome
Show Less
1 Department of Obstetrics and Gynaecology
2 Department of Nuclear Medicine
3 Department of Medical Physics, University of Patras Medical School, Rion (Greece)
Clin. Exp. Obstet. Gynecol. 2009, 36(3), 173–175;
Published: 10 September 2009
Abstract

Objective: In this prospective study, we investigated the association between mid-trimester maternal serum human chorionic gonadotropin (ms-hCG) levels and adverse pregnancy outcome in a South-Western Greek population. Materials and Methods: 130 healthy Greek women with spontaneous pregnancies were investigated for ms-hCG levels between the 13th and 24th weeks of gestation and followed for adverse pregnancy outcome. hCG levels > 2.0 multiples of the median value for gestation were considered abnormal. Statistical analysis was performed by Pearson’s chi-square test. Results: Gestational complications developed in a total of 12 of the 130 women studied (9.23%). Elevated ms-hCG levels were detected in a total of 14 of the 130 women studied (10.77%). Conclusion: Multiparameter testing of placental function in the mid-trimester (uterine artery Doppler, placental morphology and ms-hCG screening) may allow us to identify women with increased risk of developing severe placental insufficiency and pregnancy complications.
Keywords
Maternal serum hCG levels
Adverse pregnancy outcome
Share
Back to top